Cost-effectiveness analysis of a lung cancer screening program in the netherlands: a simulation based on NELSON and NLST study outcomes

Hilde ten Berge,Bo Willems,Xuanqi Pan,Evgeni Dvortsin,Joachim Aerts,Maarten J. Postma,Mathias Prokop,Michel M. van den Heuvel
DOI: https://doi.org/10.1080/13696998.2024.2404359
2024-09-21
Journal of Medical Economics
Abstract:Background In the Netherlands, lung cancer is the leading cause of cancer-related death, accounting for more than 10,000 annual deaths. Lung cancer screening (LCS) studies using low-dose computed tomography (LDCT) have demonstrated that early detection reduces lung cancer mortality. However, no LCS program has been implemented yet in the Netherlands. A national LCS program has the potential to enhance the health outcomes for lung cancer patients in the Netherlands.
medicine, general & internal,health care sciences & services
What problem does this paper attempt to address?